The method of treatment of chronic prostatitis
(57) Abstract:The invention relates to medicine, and urology. On reflex point suprapubic region VC 3 effect of pulsed electromagnetic EHF radiation. In the period between impulses in the mode of bioresonance. Use the device "Stella-1". Course 8 - 10 treatments. The method improves the efficiency of the treatment. table 2., 3 Il. The invention relates to medicine, namely to andrology and physiotherapy, and is intended for the treatment of chronic prostatitis (CP).Chronic prostatitis is the most frequent disease of male genital organs in men in the sexually active age.In recent years a marked increase in the incidence of CP. According to various authors, prostatitis occur in 30-60% of men. The treatment of CP is different difficulties because of the anatomical and physiological peculiarities of the location of the affected organs, and prostate doomed for a long period, if you are unable to deal with it in the acute phase currents, which, by the way, in many practical cases may not be (Tiktinsky O. L., Kalinin S. N., 1994). CP under different course leads to male infertility and sexual disorders for more than 50% of men.Closest to the claimed method according to the characteristics and purpose is a method of treatment of CP by applying electromagnetic radiation of mm-range wavelength 7.1 and 5.6 mm from the EHF-therapy "Yav-1" on the reflexogenic zone perineal or suprapubic area for 15-20 min (Laurent O. B., Dunaevsky, Y. L., Golant, M. B., and others, the Influence of EHF-therapy for chronic prostatitis//. Features medical-biological applications of mm-waves. -M., 1994, -n-122-127), chosen as a prototype.The disadvantages of the method are the exposure duration and the relatively low efficiency of the treatment.The aim of the invention is to increase the effectiveness of treatment of CP, reducing the time of exposure and the duration of treatment. This goal is achieved by the combined effects on the reflex point suprapubic region (VC 3) electromagnetic radiation (EMR) in the millimetre range and AMY with spectral characteristics similar to their own radiation exposure (resonance mode).In practice, the proposed method is carried out is who in the pulse mode, attached to BAHT using the patch. The design of the emitters of the apparatus corresponding to the description in the patent of Russian Federation N 2141304. This apparatus is commercially manufactured LLC "spinor", , Tomsk since 1995, entered into the State Register (registration N 95/311-198) and approved for medical applications (Order No. 6 from 28.06.1995, KMTN Russian Ministry of health, certificate of conformity N ROSS RU IU 24.H00160).Bio-mode exposure is carried out through bioresonance driver for the device "Stella-1". The emitter is put in contact on biologically active point VC3 (Fig.1).The semiconductor that forms the basis of resonance of the radiator has two stable States with different energy levels E and E . In the transition from one state to another semiconductor changes its properties (in particular, conductivity) (Fig. 2).Apparatus "Stella-1" operates in pulsed mode. During the passage of the electrical impulse through bioresonance emitter when the threshold voltage Uthenthe phase transition occurs semiconductor in energy state E, and then when the voltage U2back (Fig. 3). If at the moment of transition to the semiconductor podea this point, which leads to the suppression of pathological oscillations emitted by a point. The recorded spectrum is the bio for the patient, as recorded with his own body. For more details on this process are described in patent application N 96118712, which is referenced in our application and the patent of Russian Federation N 2141304.The emitter generates EMR mm-range: 7,1, 5,6 or 4.9 mm at the time of submission to him of the supply of the pulse. During the passage of the pulse through the emitter erases a record of the frequency-wave analogue of radiation BAHT, which are attached to the radiator for treatment procedures. Then during the absence of the supply of the pulse emitter pereizuchit AMY on the heat level with the spectral composition of the corresponding recorded, provided that the design of the radiator. Thus there is an impact on BAT: original use of EHF radiation during passage of the supply of the pulse and then with the help of AMY with spectral characteristics similar to the radiation BAHT, which leads to suppression of pathological oscillations emitted by the BAT (C. F. Claussen, 1990). In the proposed method of treatment of chronic prostatitis distinguishing feature is the impact of the point VC 3 pulse is awn up to 15 minutes, every day, on the course of 8-10 treatments.The method is as follows. At BAT VC 3 contact impose the emitter of the device, "Stella-1", thereby the impact on the area, which is the reflex for prostate cancer. The basis of the proposed mechanism of action of this factor is the recovery developed in the disease process of functional and organic disorders in the prostate gland, improvement of microcirculation in it, the normalization of parameters of General and local immunity. The choice of emitter BRT is based on the results of clinical and laboratory research, which revealed the highest effectiveness of this method compared with the use of fixed frequencies in the mm-range.The study included 88 patients with CP 1 and stage 2 in the phase of moderate deterioration and partial remission in age from 18 to 60 years with disease duration of 3 months to 20 years. Patients complained of pain of varying intensity in the groin, supra-pubic, scrotal, anal region with irradiation in the lower back, penis, inner thighs. Dysuric phenomena in the form of a fast, painful urination, weak urine stream, and a frame period, hypoalgesia and postulations pain, weakness, irritability, fatigue, poor sleep, etc.Efficacy of treatment was assessed by clinical and laboratory complex, which included: history, study of genital status, rectal digital examination of the prostate and accessory sex glands, microscopic and cytological examination of urethral scrapings and prostatic secretions. Examination of the ejaculate was carried out according to the methods recommended by who. Also conducted transabdominal and transrectal ultrasonography of the prostate gland, seminal vesicles and bladder, the study of the immunological reactivity of the organism, the study of electrical conductivity of biologically active points by the method of R. Voll. To assess the effectiveness of the proposed method was carried out clinical research. Patients with chronic prostatitis were divided into four groups. 1, 2, and 3 group (14, 12 and 15) patients receiving EHF-therapy waves 7,1, 5,6 and 4.9 mm, respectively, without mode bioresonance apparatus of the "Stella-1" on the reflex zone of the suprapubic area, duration up to 30 min daily, 10-12 procedures for the course. group 4 - 14 patients for whom in accordance with the inventive method, namely, the impulse waves with a length of 7.1 mm and the impact of mode of bioresonance in the period between pulses from device "Stella" -1" up to 15 min on a course of 8-10 treatments daily.As a result of treatment there was an improvement of the General well-being of the patients were relieved of pain and dysuric syndrome, normalized parameters prostatic secretions, semen, General and local immunity. The advantage of the proposed method in comparison with the prototype is also reducing the time of exposure and number of procedures for the course.The proposed method of treatment was used in 33 patients with chronic nonspecific prostatitis in age from 18 to 60 years with disease duration from 3 months to 20 years, aggravated violations copulative and reproductive functions. The majority of patients had previously received anti-bacterial, anti-inflammatory treatment, physiotherapeutic methods of treatment; duration of remission was not more than 2-4 months. We analyzed the results of treatment of men suffering from chronic prostatitis, the claimed method and manner of the prototype. In table. 1 presents the dynamics of clinical and laboratory parameters after treatment claimed the ate and objective evidence, normalization of cell parameters prostatic secretion occurs in 2-7 days earlier than when using effects only fixed frequency UHF-band. Side effects were not identified.Example No. 1. Patient N., 34 years old, came in andrology Department of the Tomsk scientific research Institute of balneology and physiotherapy with complaints of frequent urination, discomfort in the perineum, the weakening of adequate erections, fatigue. Considers himself ill for 1.5 years, when after suffering colds having pain in the perineum, mucous discharge from the urethra, which were spontaneously stopped after 2 weeks. Earlier treatment is not received. Admission: the prostate gland is enlarged, testovaty consistency, moderately painful to palpation, median groove smooth. In prostatic secretion: leukocyte 25-30 in the field of view, macrophages 1-3 in the field of view, lecithin grain in small quantities, cocco-bacillary flora. The concentration of circulating immune complexes in prostate secretion 150 srvc.ed. Transabdominal ultrasonography of the prostate: dimensions 35 x 48 x 30 mm, heterogeneous echostructure with multiple exonerative areas. The value of e is l units Diagnosis: chronic bacterial prostatitis under mild exacerbation.In the Department of patient treatment in accordance with the inventive method waves EHF-band mode bioresonance on BAT suprapubic region VC 3 duration 15 min, daily, on a course of 9 treatments. No side effects were observed. After treatment, no complaints. With rectal finger examination: prostate was reduced in size, elastic consistency, painless, median sulcus distinct. In prostatic secretion: leukocytes isolated fields of view, lecithin grain moderately, macrophages and microflora was not found. The concentration of circulating immune complexes 75 srvc.ed. Ultrasound of the prostate - dimensions 28 x 40 x 32 mm, echostructure homogeneous. The value of conductivity by R. Voll 60 srvc. unit control surveys for 14 months: no complaints, copulative function is normalized, laboratory values within normal limits.Example No. 2. Patient F., 26 years old, came in andrology Department with complaints of pain in the perineum and anus after intercourse, erased orgasm, difficulty and frequent urination in the months ago received the appointment of urologist antibacterial therapy, however, the improvements are not followed. With rectal finger survey: the prostate gland is enlarged, heterogeneous consistency, painful, median sulcus smooth, seminal vesicles palpation of the painful and enlarged. In prostatic secretion: leukocytes 35-50 in the field of view of the microscope, lecithin grain 8-10, the microflora is not detected. The value of conductivity by R. Voll 74 srvc.ed. Diagnosis: chronic prostatovezikulit in the acute stage. Treatment waves EHF-band mode BRT on BAT VC 3 in the amount of 10 treatments, duration of 12 minutes each day. After the end of treatment showed a disappearance of pain and dysuric phenomena, normalization of orgasm, and improve General health. Objective examination revealed a size reduction and disappearance of pain prostate gland and the seminal vesicles, the consistency of the prostate has become more homogeneous, the median furrow is expressed. In prostatic secretion: leukocytes 5-9 fields of view, lecithin grain in large quantities, the microflora is not detected. The value of conductivity by R. Voll 56.E. The follow-up period was tracked for 18 months, exacerbations was not. In table. 2 shows comparative features is ecene by the claimed method, therapeutic effect achieved in 84.8% of patients. Eliminated or significantly reduced subjective manifestations of the disease. When rectal-finger study marked decrease or disappearance of pain on palpation of the prostate, the normalization of its tone. Microscopy of prostate secretion and semen indicates a normalization of the cell parameters. There was a positive dynamics of an ultrasound image of the prostate, normalization conductivity points responsible for the functional condition of the prostate according to the method of R. Voll, improving the immunological reactivity of the organism.The study of long-term results showed that the duration of remission was eighteen years or more full normalization copulative and reproductive functions.Thus, the advantages of the method lie in the improvement of the drainage function, hemodynamics, and trophism of the prostate, i.e. the relief of the inflammatory process and the normalization of immune status. This method is easily implemented as an outpatient or in the hospital.Sources of information
1. O. L. Tiktinsky, S. N. Kalinin, the Prostate is a male disease. - C. Pb, 1994.3. Suvorov A. P., Petrosyan Century. And., Zhitenev E. A. and other Spectral wave diagnostics and resonant-wave therapy for chronic retroprosthetic// 10th Russian Symposium "Millimeter waves in medicine and biology": Sa. Reports. -M.: IRE of RAS.-1995, S. 45.4. C.-F. Claussen, Homotoxikologie (Kernstuck einer probiotischen holostischen Medizin), Aurelia-Verlag, Baden-Baden, 1990, p.70. The method of treatment of chronic prostatitis, including the effects of electromagnetic EHF radiation on the reflex point suprapubic region, characterized in that the impact of exercise on the point V 3 impulse waves with a length of 7.1 mm, and between the impulses in the mode of bioresonance apparatus of the "Stella-1", with duration of 15 min, daily, at the rate of 8 - 10 treatments.
SUBSTANCE: method involves administering diet with high content of nutrient fibers and restricted amount of ordinary hydrocarbons, animal fats and meat broth. Massage is done with manual massage machine Acupress being four-roller bronze or ebonite massage instrument operating along small intestine during 5-6min and then with movements across the abdomen from left to right during 3-4 min. The like movements are done with two-roller bronze or ebonite massage instrument operating along large intestine meridian symmetrically relative to the right and left arm during 4-5 min. All massage movements are done slowly. Procedures are given daily in the morning on empty stomach, before dinner and before going to bed.
EFFECT: enhanced effectiveness in treating chronic constipation cases.